We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.18%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$507M
Cap. Flow
+$424M
Cap. Flow %
37.86%
Top 10 Hldgs %
69.37%
Holding
669
New
238
Increased
59
Reduced
66
Closed
278

Sector Composition

Rank Sector Weight
1 Financials 8.86%
2 Healthcare 4.92%
3 Technology 4.04%
4 Communication Services 3.4%
5 Industrials 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRG icon
376
PUT
NRG Energy
NRG
$25.2B
$3K ﹤0.01%
+12,000
New +$395K
VXX icon
377
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$145M
$3K ﹤0.01%
+53
New +$68.9K
FCX icon
378
PUT
Freeport-McMoran
FCX
$96.4B
$2K ﹤0.01%
186,300
IBB icon
379
PUT
iShares Biotechnology ETF
IBB
$9.81B
$2K ﹤0.01%
20,500
FLG
380
PUT
Flagstar Bank National Association
FLG
$5.89B
$2K ﹤0.01%
+8,067
New +$223K
TTCF
381
PUT
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$2K ﹤0.01%
+35,000
New +$692K
RDUS
382
PUT
DELISTED
Radius Health, Inc.
RDUS
$2K ﹤0.01%
+5,000
New +$75.1K
PS
383
PUT
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$2K ﹤0.01%
+16,500
New +$295K
PRVL
384
CALL
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$2K ﹤0.01%
+20,000
New +$253K
CLF icon
385
PUT
Cleveland-Cliffs
CLF
$7.08B
$1K ﹤0.01%
43,200
+13,500
+45% +$137K
FAST icon
386
PUT
Fastenal
FAST
$60.1B
$1K ﹤0.01%
20,000
M icon
387
PUT
Macy's
M
$6.45B
$1K ﹤0.01%
118,200
-2,224,000
-95% -$19M
SLV icon
388
PUT
iShares Silver Trust
SLV
$31.5B
$1K ﹤0.01%
+4,000
New +$91K
WKHS icon
389
PUT
Workhorse Group
WKHS
$34.1M
$1K ﹤0.01%
+18
New +$1.17M
PRSP
390
PUT
DELISTED
Perspecta Inc. Common Stock
PRSP
$1K ﹤0.01%
+3,800
New +$81.6K
TIF
391
CALL
DELISTED
Tiffany & Co.
TIF
$1K ﹤0.01%
59,900
-690,700
-92% -$88.4M
ABBV icon
392
AbbVie
ABBV
$442B
-3,222
Closed -$310K
ABUS icon
393
CALL
Arbutus Biopharma
ABUS
$923M
-25,000
Closed -$8K
ABUS icon
394
PUT
Arbutus Biopharma
ABUS
$923M
-25,000
Closed -$58K
ACAD icon
395
CALL
Acadia Pharmaceuticals
ACAD
$5.07B
-20,500
Closed -$33K
ACAD icon
396
Acadia Pharmaceuticals
ACAD
$5.07B
-1,417
Closed -$58K
ACAD icon
397
PUT
Acadia Pharmaceuticals
ACAD
$5.07B
-20,800
Closed -$51K
ADN
398
DELISTED
Advent Technologies
ADN
-3,333
Closed -$1.03M
ADNWW
399
DELISTED
Advent Technologies Holdings Warrant
ADNWW
-14,939
Closed -$10K
ADV icon
400
Advantage Solutions
ADV
$387M
-2,000
Closed -$523K

Similar funds

Cowen and Company's Q4 2020 Portfolio in Review

As of Q4 2020, Cowen and Company held 669 positions worth $1.12B, up 83% from $613M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Cowen and Company deployed $424M of net new capital in Q4 2020, opening 238 new positions and adding to 59 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 825,000 shares worth $114M.

By sector, the portfolio is most concentrated in Financials at 8.9% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was McDonald's, an estimated $10.2M trimmed.

  • Cowen and Company's largest Q4 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 825,000 shares worth $114M.
  • Cowen and Company added most to Invesco QQQ Trust in Q4 2020, an estimated $68.6M increase.
  • Cowen and Company's biggest Q4 2020 reduction was McDonald's, cutting an estimated $10.2M.
  • Cowen and Company fully exited Nikola Corporation Common Stock in Q4 2020, selling an estimated $40M.
  • Cowen and Company's ten largest holdings make up 69% of its $1.12B portfolio in Q4 2020.
  • Cowen and Company opened 238 new positions and closed 278 in Q4 2020.
  • Cowen and Company's portfolio value rose 83% quarter-over-quarter to $1.12B.

Based on Cowen and Company's 13F filing for Q4 2020, filed 8 Feb 2021.